Agata Boxe

All articles by Agata Boxe

The MET alteration occurs in 3% to 4% of patients with the condition.

Lung Cancer

Tepotinib Yields High Partial Response Rates in NSCLC With MET Alterations

Agata Boxe

October 26, 2020

The MET alteration occurs in 3% to 4% of patients with the condition.

Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.

General Pulmonology

How the Coronavirus Pandemic May Affect Cancer Clinical Trials

Agata Boxe

October 14, 2020

Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.

Next post in General Pulmonology

Agata Boxe

All articles by Agata Boxe

Tepotinib Yields High Partial Response Rates in NSCLC With MET Alterations

How the Coronavirus Pandemic May Affect Cancer Clinical Trials

SARS-CoV-2 Antibody Testing Linked to Increase in First-Time Blood Donors